Welby Inc

Chart & Performance

D1W1MN

P/E

—

P/S

3.36

EPS

—

Div Yield, %

—

Shrs. gr., 5y

1.15%

Rev. gr., 5y

-5.97%

Revenues

636m

+20.39%

Net income

-540m

L-32.93%

CFO

-329m

L-45.42%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health conditions, encompassing diabetes mellitus, lifestyle-related diseases, mental health disorders, autoimmune and neurological diseases, rare conditions, oncology, and pain management. Furthermore, Welby is active in medical data surveying and operates its signature platform, Welby My Carte.

URL

https://welby.jp/

IPO date

Mar 29, 2019

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT